ASSOCIATION BETWEEN OSTEOPROTEGERIN GENE POLYMORPHISMS AND RISK OF CORONARY ARTERY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Jia P, Wu N, Jia D*, Sun Y*
*Corresponding Author: Professor Dalin Jia and/or Professor Yingxian Sun, Department of Cardiology, The First Affiliated Hospital of China Medical University, 155th North Nanjing Street, Heping District, Shenyang 110001, Liaoning Province, People’s Republic of China. Tel: +86-242-326-9477. Fax: +86-242-326-9477. Email: jdl2001@126.com and/or yxsun@mail.cmu.edu.cn
page: 27

MATERIALS AND METHODS

Search Strategy. A systematic search assembling the following terms: genetic polymorphism, single nucleotide polymorphism, gene mutation, genetic variants, coronary atherosclerosis, myocardial ischemia, acute coronary syndrome, coronary artery disease, myocardial infarction, ischemic heart disease, TNFRSF11B, osteoprotegerin, was conducted in PubMed, Web of Science, Cochrane Library, Chinese National Knowledge Infrastructure (CNKI) and Chinese Wan Fang databases up to May 1 2017 to identify all potentially relevant studies. Hand-searching was carried out to determine other potential eligible studies through scanning the references cited in the retrieved articles. The full-text articles were further reviewed to determine whether they were included in the final analysis strictly based on eligibility criteria. If two reviewers disagreed, all the authors critically evaluated the studies to judge of the inclusion or exclusion of a certain study. Eligibility Criteria. All the eligible articles were supposed to meet the following major inclusion criteria: i) assessment of the association between OPG gene polymorphisms and CAD; ii) case-control or cohort studies; iii) data provided by articles about allele frequency should be sufficient for calculating genotypic odds ratio (OR) with corresponding to 95% confidence interval (95% CI) in cases and controls. Moreover, only when a single nucleotide polymorphism (SNP) in the OPG gene was reported by at least two articles would it be analyzed by meta-analysis. Studies were excluded when they were i) duplicated data; ii) case report, review articles and editorial comment. The diagnosis of the CAD case was based on the WHO criteria for CAD as previously described (stenosis ≥50.0% of the diameter in at least one major coronary artery based on computerassisted assessments) [17]. All healthy control subjects were identified according to patient history, serum biochemistry examination and electrocardiogram (ECG) test. Data Extraction. Data extraction was performed independently by two authors using a standardized data extraction form including following elements: 1) author’s name, year of publication; 2) patient characteristics of each group; 3) number of participants in case and control groups; 4) study type; 5) genotyping method; 6) p value of Hardy-Weinberg equilibrium (HWE) test in the control; 7) OR and 95% CI for association with CAD. Assessment of the quality of studies was performed using the Newcastle- Ottawa Scale (NOS) as previously described [18]. Briefly, two authors of this article separately evaluated the quali- ties based on eight items and scored the studies from 0 to 9 points. Studies with a score not less than seven points were considered to be of high quality. Discrepancy was resolved as described above. Statistical Analyses. First, the genotype frequencies of the OPG gene polymorphism among the controls of all included studies were assessed under HWE using a χ2 goodness- of-fit test. Odds ratios with corresponding 95% CIs were used to estimate the strength of association between OPG gene polymorphisms and CAD. The between-study heterogeneity across all eligible comparisons was tested by the χ2-based Q statistic. Heterogeneity was considered significant when the p value was less than 0.10. When heterogeneity existed, the random effects model was performed to calculate the pooled OR of each eligible study, otherwise, the fixed effect model was used. Generally, we assessed the association between the OPG gene polymorphism and CAD under five genetic models: allele, homozygote, heterozygote, dominant and recessive models. Sensitivity analysis was conducted through omitting one study at a time to examine its influence on the overall estimate to evaluate the stability of the meta-analysis. Publication bias was also analyzed using the Egger’s linear regression test and funnel plots and publication bias was considered present when the p value was less than 0.05. All statistical analyses were done using STATA version 11.0 (STATA Corporation, College Station, TX, USA). All p values were two-tailed.



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006